BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18503530)

  • 1. Primary cutaneous epidermotropic marginal zone B-cell lymphoma: a role for antihistamines in maintaining lymphoma cell growth?
    Pavlović MD; Kamarachev J; Adamic M
    J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):1012-4. PubMed ID: 18503530
    [No Abstract]   [Full Text] [Related]  

  • 2. Pediatric primary cutaneous marginal zone lymphoma: in association with chronic antihistamine use.
    Sroa N; Magro CM
    J Cutan Pathol; 2006 Sep; 33 Suppl 2():1-5. PubMed ID: 16972944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary cutaneous marginal zone B-cell lymphoma: clinical and histological aspects.
    Khaled A; Sassi S; Fazaa B; Ben Hassouna J; Ben Romdhane K; Kamoun MR
    Pathologica; 2009 Feb; 101(1):18-20. PubMed ID: 19771768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Marginal zone B-cell lymphoma affecting the skin: histological and phenotypic study of 49 cases].
    Bathelier E; Thomas L; Balme B; Coiffier B; Berger F; Ffrench M; Salles G; Dalle S
    Ann Dermatol Venereol; 2008 Nov; 135(11):748-52. PubMed ID: 19061653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary cutaneous marginal zone B-cell lymphomas: are they different from other extranodal marginal zone B-cell lymphomas?
    Ferenczi K
    J Cutan Pathol; 2009 Jun; 36(6):715-7. PubMed ID: 19515055
    [No Abstract]   [Full Text] [Related]  

  • 6. Asymptomatic bone marrow involvement in patients presenting with cutaneous marginal zone B-cell lymphoma.
    Bathelier E; Thomas L; Balme B; Coiffier B; Salles G; Berger F; Ffrench M; Sebban C; Biron P; Dalle S
    Br J Dermatol; 2008 Aug; 159(2):498-500. PubMed ID: 18547317
    [No Abstract]   [Full Text] [Related]  

  • 7. Cutaneous marginal zone B-cell lymphoma in the setting of fluoxetine therapy: a hypothesis regarding pathogenesis based on in vitro suppression of T-cell-proliferative response.
    Breza TS; Zheng P; Porcu P; Magro CM
    J Cutan Pathol; 2006 Jul; 33(7):522-8. PubMed ID: 16872479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermotropic skin involvement of splenic marginal zone B-cell lymphoma: a diagnostic challenge.
    Baykal C; Erdem S; Kılıç S; Nalçacı M; Büyükbabani N
    J Cutan Pathol; 2017 Mar; 44(3):312-314. PubMed ID: 28008643
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary Breast Lymphoma with cutaneous involvement in a patient with Rheumatoid Arthritis - a complication of infliximab therapy?
    Costa C; Aguiar R; Rodrigues M; Carvalho P; Ferreira J; Santiago M; Rito L; Silva J; Duarte C; da Silva J; Malcata A
    Acta Reumatol Port; 2017; 42(2):191-195. PubMed ID: 28375194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose palliative radiotherapy for cutaneous B- and T-cell lymphomas.
    Neelis KJ; Schimmel EC; Vermeer MH; Senff NJ; Willemze R; Noordijk EM
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):154-8. PubMed ID: 18834672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric MALT lymphoma in a patient receiving infliximab for psoriasis.
    Girard C; Guillot B; Bessis D
    Br J Dermatol; 2008 Aug; 159(2):497-8. PubMed ID: 18547313
    [No Abstract]   [Full Text] [Related]  

  • 12. Some remarks on cutaneous marginal zone lymphoma.
    Fernandez-Flores A
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):648-9. PubMed ID: 18363682
    [No Abstract]   [Full Text] [Related]  

  • 13. Composite marginal zone B cell lymphoma and enteropathy-type T cell lymphoma of the stomach: a case report.
    Yun WK; Ko YH; Kim DS; Kim WS; Rhee PL; Kwak SY; Jang TH; Choi WS
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):791-5. PubMed ID: 18617785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous marginal zone lymphoma--still under study.
    Delli FS
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):649-50. PubMed ID: 18363681
    [No Abstract]   [Full Text] [Related]  

  • 15. Is there a cutaneous variant of marginal zone hyperplasia?
    Guitart J; Gerami P
    Am J Dermatopathol; 2008 Oct; 30(5):494-6. PubMed ID: 18806498
    [No Abstract]   [Full Text] [Related]  

  • 16. Secondary cutaneous vasculitislike MALT lymphoma with an IGL-MYC fusion.
    Kaune KM; Baumgart M; Gesk S; Middel P; Ghadimi BM; Siebert R; Bertsch HP; Schön MP; Neumann C
    Arch Dermatol; 2009 Aug; 145(8):955-8. PubMed ID: 19687442
    [No Abstract]   [Full Text] [Related]  

  • 17. Two pediatric cases of primary cutaneous B-cell lymphoma and review of the literature.
    Sharon V; Mecca PS; Steinherz PG; Trippett TM; Myskowski PL
    Pediatr Dermatol; 2009; 26(1):34-9. PubMed ID: 19250402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of B-cell clonality using the BIOMED-2 PCR method effectively distinguishes cutaneous B-cell lymphoma from benign lymphoid infiltrates.
    Morales AV; Arber DA; Seo K; Kohler S; Kim YH; Sundram UN
    Am J Dermatopathol; 2008 Oct; 30(5):425-30. PubMed ID: 18806482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nodal marginal zone lymphoma in association with hydroa vacciniforme-like papulovesicular eruption, hypersensitivity to mosquito bites and insect bite-like reaction.
    Yoon TY; Kim YG; Kim JW; Kim MK
    Br J Dermatol; 2005 Jul; 153(1):210-2. PubMed ID: 16029356
    [No Abstract]   [Full Text] [Related]  

  • 20. High-resolution genome-wide array comparative genomic hybridization in splenic marginal zone B-cell lymphoma.
    Novara F; Arcaini L; Merli M; Passamonti F; Zibellini S; Rizzi S; Rattotti S; Rumi E; Pascutto C; Vetro A; Astori C; Boveri E; Lucioni M; Paulli M; Zuffardi O; Lazzarino M
    Hum Pathol; 2009 Nov; 40(11):1628-37. PubMed ID: 19647853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.